ORIX (NYSE:IX – Get Free Report) issued its quarterly earnings results on Monday. The real estate investment trust reported $2.56 EPS for the quarter, beating analysts’ consensus estimates of $2.50 by $0.06, Zacks reports. ORIX had a net margin of 14.08% and a return on equity of 10.01%.
ORIX Stock Performance
NYSE IX opened at $106.56 on Tuesday. ORIX has a 1 year low of $90.57 and a 1 year high of $125.84. The company has a debt-to-equity ratio of 1.38, a current ratio of 1.40 and a quick ratio of 1.37. The stock has a market capitalization of $25.89 billion, a PE ratio of 9.19, a P/E/G ratio of 1.08 and a beta of 0.92. The company’s 50 day simple moving average is $106.91 and its two-hundred day simple moving average is $111.56.
Wall Street Analysts Forecast Growth
Separately, StockNews.com lowered shares of ORIX from a “buy” rating to a “hold” rating in a report on Wednesday, November 20th.
Insider Activity
In other ORIX news, major shareholder Corp Orix sold 3,700,000 shares of the firm’s stock in a transaction on Friday, December 13th. The shares were sold at an average price of $75.38, for a total value of $278,906,000.00. Following the sale, the insider now owns 2,976,077 shares of the company’s stock, valued at $224,336,684.26. This trade represents a 55.42 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.08% of the company’s stock.
ORIX Company Profile
ORIX Corporation provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East. The company's Corporate Financial Services and Maintenance Leasing segment is involved in the finance and fee; leasing and rental of automobiles, electronic measuring instruments, and ICT-related equipment businesses; and provision of life insurance and environment and energy-related products and services.
Further Reading
- Five stocks we like better than ORIX
- Breakout Stocks: What They Are and How to Identify Them
- Monday.com Stock Could Soar to New Highs—Here’s How
- The How and Why of Investing in Gold Stocks
- Merck: 4 No-Brainer Reasons to Buy This Dip
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
Receive News & Ratings for ORIX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ORIX and related companies with MarketBeat.com's FREE daily email newsletter.